Evidence map›Paper›PMID 33911481›Full record

ArticleAnnals of dermatology2018

Evaluation of the Interventional Approaches in the Management of Cutaneous Leishmaniasis in Jazan: An Observational Study.

Hafiz A Makeen, Mohammed A Buraik, Santhosh Joseph Menachery, Khalid M Alattas, Abdulkarim M Meraya

Open access · hybridAbstract read
In one paragraph

Article in Annals of dermatology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 87% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Hafiz A MakeenDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Mohammed A BuraikDepartments of Dermatology and Pathology, King Fahd Central Hospital, Jazan, Saudi Arabia.
Santhosh Joseph MenacheryDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.ORCID https://orcid.org/0000-0003-1505-9163
Khalid M AlattasDepartment of Dermatology, King Fahd Central Hospital, Jazan, Saudi Arabia.
Abdulkarim M MerayaDepartment of Clinical Pharmacy, Faculty of Pharmacy, Jazan University, Jazan, Saudi Arabia.
Jazan University · SAKing Fahad Central Hospital · SA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCutaneous leishmaniasis is a tropical infection of public health importance. Numerous treatment approaches are in practice with variable degree of success however its management has no universal consensus or practice guidelines to follow.

objectiveAnalyze the management of cutaneous leishmaniasis retrospectively at a central hospital of Jazan Province, Kingdom of Saudi Arabia to identify the current treatment pattern and compare the outcomes.

methodsThis cross-sectional study was conducted based on the hospital records of patients who attended the dermatology clinic for cutaneous leishmaniasis during the year 2012 to 2015.

resultsForty three patients were included in the study. There was a male preponderance (65.1%) among the patients and 60.5% of them were of pediatric age group. Monotherapy was the initial choice for 58.1% of the patients. Intralesional sodium stibogluconate (SS-IL) was the most preferred treatment for initial therapy, as monotherapy and as part of combination therapy. A complete response was achieved in 22 patients (51.2%) with initial therapy. Among the different treatment groups, SS-IL+itraconazole showed significantly higher complete response rate compared to other treatments offered as initial therapy (

conclusionThe findings and observations suggest that initial combination therapy with SS-IL+itraconazole significantly improved the complete response rates and thus reduced the need for additional or prolonged therapies.

Indexed as

Cutaneous leishmaniasisIntralesional injectionsItraconazoleLeishmania majorLeishmania tropica

Identifiers

PMID33911481
PMCPMC7992491
OpenAlexW2889175787

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.